Abstract:Angewandte Chemie International EditionVolume 44, Issue 18 p. 2704-2707 Communication Terphenyl-Based Helical Mimetics That Disrupt the p53/HDM2 Interaction† Hang Yin, Hang Yin Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this authorGui-in Lee, Gui-in Lee Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this authorHyung Soon Park, Hyung Soon Park Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this authorGregory A. Payne, Gregory A. Payne Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this authorJohanna M. Rodriguez, Johanna M. Rodriguez Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this authorSaid M. Sebti Prof., Said M. Sebti Prof. Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, Departments of Oncology and Biochemistry and Molecular Biology, University of South Florida, Tampa, FL 33612, USASearch for more papers by this authorAndrew D. Hamilton Prof., Andrew D. Hamilton Prof. andrew.hamilton@yale.edu Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this author Hang Yin, Hang Yin Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this authorGui-in Lee, Gui-in Lee Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this authorHyung Soon Park, Hyung Soon Park Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this authorGregory A. Payne, Gregory A. Payne Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this authorJohanna M. Rodriguez, Johanna M. Rodriguez Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this authorSaid M. Sebti Prof., Said M. Sebti Prof. Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, Departments of Oncology and Biochemistry and Molecular Biology, University of South Florida, Tampa, FL 33612, USASearch for more papers by this authorAndrew D. Hamilton Prof., Andrew D. Hamilton Prof. andrew.hamilton@yale.edu Department of Chemistry, Yale University, P.O. Box 208 107, New Haven, CT 06520-8107, USA, Fax: (+1) 203-432-6144Search for more papers by this author First published: 25 April 2005 https://doi.org/10.1002/anie.200462316Citations: 207 † We thank the National Institutes of Health for support of this work (GM35208 and GM69850). The HDM2 pQE40 construct was kindly provided by Dr. Christian Klein (Hoffmann-La Roche, Inc.). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract HDM2 regulates p53 by binding to its transactivation domain and promoting its ubiquitin-dependent degradation. Crystallographic analysis of the HDM2/p53 complex revealed that three hydrophobic residues (F19, W23, L26) along one face of the p53 helical peptide are essential for binding (see picture). Terphenyl-based antagonists mimic the α-helical region of p53 and disrupt HDM2/p53 complexation. Citing Literature Supporting Information Supporting information for this article is available on the WWW under http://www.wiley-vch.de/contents/jc_2002/2005/z462316_s.pdf or from the author. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume44, Issue18April 29, 2005Pages 2704-2707 RelatedInformation

An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2

Inhibition of Nonsense-Mediated Decay Rescues Functional P53β/γ Isoforms in MDM2-amplified Cancers

Inhibition of Nonsense-Mediated Decay Rescues P53β/γ Isoform Expression and Activates the P53 Pathway in MDM2-overexpressing and Select P53-Mutant Cancers

Inhibition of nonsense-mediated decay rescues p53/ isoform expression and activates the p53 pathway in and select-mutant cancers

Negative Regulation Of Hdm2 To Attenuate P53 Degradation By Ribosomal Protein L26

The central region of HDM2 provides a second binding site for p53

Regulation of HDM2 activity by the ribosomal protein L11

Small Molecule Inhibitors of the P53-Mdm2

Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells

Hdm2 Disrupts HdmX-mediated Nuclear Export of P53 by Sequestering It in Nucleus

Abstract 2785: Discovery of a Novel HDM2 Inhibitor with Potent in Vivo Anti-Tumor Activity

Abstract 4534: A Novel and Potent Small Molecule Antagonist of HDM2, SCH 1450206, Activates the P53 Pathway with Mechanism-Based Activity

HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53

Terphenyl‐Based Helical Mimetics That Disrupt the P53/hdm2 Interaction

Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53

P53 Alpha-Helix Mimetics Antagonize P53/mdm2 Interaction and Activate P53.

Mdm-2 binding and TAFII31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21

HMGA2 Promotes Intestinal Tumorigenesis by Facilitating MDM2‐mediated Ubiquitination and Degradation of P53

Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study

Structural adaptation of secondary p53 binding sites on MDM2 and MDMX